A Study Comparing Transperineal Ultrasound, Magnetic Resonance Imaging, Endoscopic Ultrasound, and Examination Under Anesthesia to Detect and Classify Perianal Fistulas in Patients With Crohn's Disease or Fistulas of Unknown Cause
TRANSIT CD
A Quadrimodal Comparison of Transperineal Ultrasound and Magnetic Resonance Imaging-based Sonographic Investigation With Integrated Testing Using Endoscopic Ultrasound and Examination Under Anesthesia for the Assessment of Perianal Fistulas in Patients With Crohn's Disease and Fistulas of Cryptogenic Origin (TRANSIT-CD Study)
1 other identifier
interventional
50
1 country
1
Brief Summary
The goal of this study is to learn how well different imaging tests detect and describe perianal fistulas in adults with Crohn's disease or fistulas with no known cause (cryptogenic). Perianal fistulas are painful tunnels that form near the anus and can lead to discharge, swelling, or infection. The main questions this study aims to answer are: How accurate is transperineal ultrasound (TPUS) compared to magnetic resonance imaging (MRI) in finding fistulas? How well do these tests identify key features like internal openings and abscesses? Do the test results help doctors make better treatment decisions? Researchers will compare TPUS and MRI to two other imaging methods: Endoscopic ultrasound (EUS), which uses a small camera and ultrasound inside the rectum Examination under anesthesia (EUA), in which a surgeon checks the area while the participant is asleep All participants will: Be adults between the ages of 18 and 75 Have a suspected or confirmed perianal fistula Be able to complete all four tests-TPUS, MRI, EUS, and EUA-within 10 days Participants will not receive any experimental treatments. The tests are part of routine care and will be done using advanced equipment by expert doctors. Each test result will be used to compare how accurate and useful the test is in real-life diagnosis and treatment planning. This study may help make fistula diagnosis faster, safer, and more affordable-especially in settings where access to MRI or surgery is limited. It may also support the use of TPUS as a first step in evaluating perianal fistulas in people with Crohn's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 25, 2025
CompletedFirst Submitted
Initial submission to the registry
August 3, 2025
CompletedFirst Posted
Study publicly available on registry
August 31, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
August 31, 2026
August 1, 2026
1.7 years
August 3, 2025
August 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Per-lesion sensitivity of transperineal ultrasound (TPUS) and magnetic resonance imaging (MRI) for detecting perianal fistulas
To determine and compare the diagnostic sensitivity of TPUS and MRI for identifying individual fistulous tracts, using endoscopic ultrasound (EUS) as the reference standard and examination under anesthesia (EUA) as the gold standard.
Within 10 days of enrollment (all four imaging modalities completed within this window)
Secondary Outcomes (4)
Sensitivity of TPUS vs MRI for detecting internal openings
Within 10 days of enrollment
Classification accuracy (Parks criteria) of transperineal ultrasound (TPUS) versus magnetic resonance imaging (MRI)
Within 10 days of enrollment
Sensitivity of transperineal ultrasound (TPUS) vs magnetic resonance imaging (MRI) for detecting perianal abscesses
Within 10 days of enrollment
Impact on clinical management based on imaging modality
Up to 14 days after imaging
Study Arms (1)
Single Group: Quadrimodal Imaging Assessment
EXPERIMENTALAll participants in this arm will undergo four diagnostic imaging procedures-transperineal ultrasound (TPUS), magnetic resonance imaging (MRI), endoscopic ultrasound (EUS), and examination under anesthesia (EUA)-in a predefined sequence. Each imaging modality will be used to evaluate the presence, type, and extent of perianal fistulas. This single-arm design allows within-subject comparison of diagnostic accuracy and clinical impact across modalities.
Interventions
Participants will undergo TPUS using a high-frequency linear and microconvex probe to evaluate fistula tracts, internal openings, and abscesses.
MRI of the pelvis will be performed using standardized T2-weighted, STIR, and post-contrast sequences for anatomical characterization of fistulas.
EUS of the anorectal canal will be performed using a linear echoendoscope to visualize internal openings, fistula tracts, and perirectal collections. EUS serves as the reference standard.
Participants will undergo EUA by a colorectal surgeon to probe fistula tracts and identify internal openings. EUA serves as the gold standard comparator.
Eligibility Criteria
You may qualify if:
- Adults between 18 and 75 years of age
- Clinical suspicion or diagnosis of perianal fistula
- Fistula etiology can be Crohn's disease or cryptogenic/tubercular (non-Crohn's)
- Ability to undergo all four imaging procedures (TPUS, MRI, EUS, and EUA) within a 10-day period
- Willing and able to provide written informed consent
You may not qualify if:
- Known or suspected anorectal malignancy
- Pregnancy or breastfeeding
- Contraindications to any of the imaging procedures:
- MRI (e.g., presence of metal implants or claustrophobia)
- EUS (e.g., severe anal stenosis or intolerance to procedure)
- Anesthesia required for EUA (e.g., significant cardiopulmonary disease)
- Prior surgery or seton placement at the index fistula site
- Incomplete or failed imaging in any one of the modalities
- Inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asian Institute of Gastroenterology
Hyderabad, Telanagana, 500082, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Although outcome assessors for each imaging modality (TPUS, MRI, EUS, EUA) are independently blinded to the findings of other modalities, the study design is a single-arm diagnostic comparison. Therefore, "No Masking" is selected to comply with ClinicalTrials.gov system requirements.
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 3, 2025
First Posted
August 31, 2026
Study Start
July 25, 2025
Primary Completion (Estimated)
April 15, 2027
Study Completion (Estimated)
April 30, 2027
Last Updated
August 31, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared publicly due to the nature of the diagnostic imaging data, which includes potentially identifiable health information. Data will be stored securely and used only by the study team for the purpose of predefined analyses. Any future data sharing will require additional ethical approval and participant consent.